β-グルカン市場：供給源（穀類、キノコ、酵母、海藻）、用途（食品・飲料、パーソナルケア、医薬品、栄養補助食品、動物飼料）、地域（北米、欧州、APAC、中南米、RoW）別 - 2028年までの世界予測

Beta-Glucan Market by Source (Cereal, Mushroom, Yeast and Seaweed), Application (Food & Beverage, Personal Care, Pharmaceutical, Dietary Supplement, Animal Feed), and Region (North America, Europe, APAC, Latin America and RoW) - Global Forecast to 2028

ベータグルカン市場は、2023年の501 Million USDから2028年には734 Million USDに成長すると予測され、予測期間中のCAGRは7.9%に達するとされています。この市場は、食品・飲料製品における天然添加物の使用需要... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年4月27日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	260	293	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

ベータグルカン市場は、2023年の501 Million USDから2028年には734 Million USDに成長すると予測され、予測期間中のCAGRは7.9%に達するとされています。この市場は、食品・飲料製品における天然添加物の使用需要の増加、食物繊維を多く含む健康的な食生活の増加、健康上の利点があるβ-グルカンの受容率の上昇によって成長すると予測されています。このような要因により、β-グルカンの新製品を開発・展開する必要性が高まっています。D
2023年には、穀物・シリアルというセグメントが最大のシェアを占めると予想されています。
穀物および穀類は、他の食品源と比較してβ-グルカンの含有量が比較的高いことで知られています。例えば、オーツ麦と大麦は特に高いレベルのβ-グルカンを含み、オーツ麦は最も豊富な食物源の一つです。穀類に含まれるβ-グルカンは、一般的に混合結合型であり、免疫調整作用やコレステロール低下作用など、健康に好ましい効果があることが示されている。穀類に含まれるβ-グルカンの含有量は高く、この有益な化合物を抽出するための望ましい供給源となる。

アプリケーション分野では、予測期間中、食品・飲料分野が市場を支配すると予測されています。
用途別では、予測期間中、食品・飲料分野が市場を支配すると予測されています。健康的な食生活に対する消費者の意識の高まり、ベーカリー、チューインガム、ミルク・タンパク質飲料、インスタント飲料などでのβ-グルカンの使用が、β-グルカンの採用につながっています。
2023年には、アジア太平洋地域が最も速い市場シェアを占めると予想されています。
ベータグルカン市場産業は、北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、その他の地域で調査されています。2023-2028年の予測期間中、アジア太平洋地域が最も速い市場を占めています。中国やインドなどのアジア太平洋諸国では原材料が容易に入手できること、健康的な食品消費パターンの増加、日本や韓国などの国々では化粧品の使用が増加していることから、アジア太平洋市場は今後数年間でかなりの成長を遂げると考えられます。

β-グルカン市場の主要参入企業のプロファイルのブレークアップ：
- バリューチェーン別：製造業者-85%、供給業者-15
- 役職別CXO：33.7％、マネージャー：44％、エグゼクティブ：22.3
- 地域別北米：60％、欧州：18％、アジア太平洋地域：10％、南米：8％、その他の地域：4
主な企業は、Tate & Lyle PLC（英国）、Kerry Group PLC（アイルランド）、Koninklijke DSM NV（オランダ）、International Flavors & Fragrances INC.（米国）、Merck（米国）です。
調査対象範囲です：
この調査レポートは、βグルカン市場を供給源（穀物・穀類、キノコ、酵母、海藻）、カテゴリー（水溶性、不溶性）、用途（食品・飲料、パーソナルケア、医薬品、栄養補助食品、動物飼料）、地域（北米、欧州、アジア太平洋、南米、その他の地域）で分類しています。本レポートの範囲は、β-グルカン市場の成長に影響を与える推進要因、阻害要因、課題、機会などの主要要因に関する詳細情報をカバーしています。主要な業界プレイヤーを詳細に分析し、事業概要、ソリューション、サービス、主要戦略、契約、パートナーシップ、協定、新製品・サービスの発表、M&A、脱石油レシチン市場に関連する最近の動向に関する洞察を提供しています。脱石油レシチン市場のエコシステムにおける今後の新興企業の競争力分析も本レポートでカバーしています。
本レポートを購入する理由
本レポートは、β-グルカン市場全体とサブセグメントの収益数値の最も近い近似値に関する情報を提供し、本市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争環境を理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立つでしょう。また、市場の鼓動を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報をステークホルダーに提供するのに役立ちます。
本レポートは、以下のポイントに関する洞察を提供します：
- βグルカン市場の成長に影響を与える主要な促進要因（消費者の健康意識の高まりと健康支出の増加、異なる産業におけるβグルカンの用途の拡大）、抑制要因（βグルカンを管理する規制基準の不一致）、機会（未開発のβグルカン用途）、課題（消費者の認識不足）の分析。
- 製品開発/イノベーション：βグルカン市場における今後の技術、研究開発活動、新製品・新サービスの発売に関する詳細なインサイトを提供します。
- 市場開発：有利な市場に関する包括的な情報 - 本レポートでは、さまざまな地域のβ-グルカン市場を分析しています。
- 市場の多様化：βグルカン市場における新製品・サービス、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。
- 競争力評価：ベータグルカン市場戦略におけるTate & Lyle PLC（英国）、Kerry Group PLC（アイルランド）、Koninklijke DSM NV（オランダ）、International Flavors & Fragrances INC.（米国）、Merck（米国）などの主要企業の市場シェア、成長戦略、サービス提供について詳しく評価します。また、本レポートは、スターターカルチャー市場を理解し、主要な市場促進要因、阻害要因、課題、および機会に関する情報を関係者に提供します。

ページTOPに戻る

1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.3 STUDY SCOPE 34
FIGURE 1 MARKET SEGMENTATION 34
1.3.1 INCLUSIONS & EXCLUSIONS 34
1.4 REGIONS COVERED 35
1.5 PERIODIZATION CONSIDERED 35
1.6 UNITS CONSIDERED 36
1.6.1 CURRENCY CONSIDERED 36
TABLE 1 USD EXCHANGE RATES, 2017–2022 36
1.6.2 VOLUME UNIT CONSIDERED 37
1.7 STAKEHOLDERS 37
1.8 SUMMARY OF CHANGES 37
1.8.1 RECESSION IMPACT ANALYSIS 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
FIGURE 2 BETA GLUCAN MARKET: RESEARCH DESIGN 39
2.1.1 SECONDARY DATA 40
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 41
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key industry insights 41
2.1.2.3 Breakdown of primaries 42
2.2 MARKET SIZE ESTIMATION 43
2.2.1 APPROACH ONE: TOP-DOWN 43
FIGURE 3 BETA-GLUCAN MARKET SIZE ESTIMATION – TOP-DOWN APPROACH 43
2.2.2 APPROACH TWO: BOTTOM-UP 44
FIGURE 4 BETA-GLUCAN MARKET SIZE ESTIMATION – BOTTOM-UP APPROACH 44
2.3 DATA TRIANGULATION 45
FIGURE 5 DATA TRIANGULATION METHODOLOGY 45
2.4 STUDY ASSUMPTIONS 46
2.5 STUDY LIMITATIONS 47
2.6 RECESSION IMPACT ON BETA-GLUCAN MARKET 47
2.6.1 MACROECONOMIC INDICATORS OF RECESSION 47
FIGURE 6 INDICATORS OF RECESSION 48
FIGURE 7 GLOBAL INFLATION RATE, 2011–2021 48
FIGURE 8 GLOBAL GDP, 2011–2021 (USD TRILLION) 49
FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON BETA-GLUCAN MARKET 50
FIGURE 10 BETA-GLUCAN MARKET: PREVIOUS FORECAST VS. RECESSION FORECAST 50
3 EXECUTIVE SUMMARY 52
FIGURE 11 BETA-GLUCAN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION) 53
FIGURE 12 BETA-GLUCAN MARKET, BY CATEGORY, 2023 VS. 2028 (USD MILLION) 53
FIGURE 13 BETA-GLUCAN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 54
FIGURE 14 BETA-GLUCAN MARKET SNAPSHOT, BY REGION 54
4 PREMIUM INSIGHTS 56
4.1 BRIEF OVERVIEW OF BETA-GLUCAN MARKET 56
FIGURE 15 GROWTH IN HEALTH-CONSCIOUS POPULATION TO DRIVE BETA-GLUCAN MARKET 56
4.2 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE & COUNTRY 57
FIGURE 16 GRAINS & CEREALS AND US DOMINATED RESPECTIVE SEGMENTS IN NORTH AMERICAN MARKET IN 2022 57
4.3 BETA-GLUCAN MARKET, BY APPLICATION & REGION 57
FIGURE 17 FOOD & BEVERAGE SEGMENT DOMINATED MARKET ACROSS ALL REGIONS IN 2022 (USD MILLION) 57
4.4 BETA-GLUCAN MARKET, BY KEY COUNTRY 58
FIGURE 18 CHINA AND INDIA TO BE MOST LUCRATIVE MARKETS FOR BETA-GLUCAN 58
4.5 BETA-GLUCAN MARKET, BY CATEGORY 59
FIGURE 19 NORTH AMERICA TO DOMINATE BETA-GLUCAN MARKET AMONG ALL REGIONS THROUGH FORECAST PERIOD 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MACROECONOMIC INDICATORS 60
5.2.1 RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES 60
FIGURE 20 NUMBER OF NEW CANCER CASES FOR ALL AGES, 2015–2020 (MILLION) 61
5.2.2 INCREASE IN CONSUMPTION OF DIETARY FIBERS 61
5.3 MARKET DYNAMICS 62
FIGURE 21 MARKET DYNAMICS: BETA-GLUCAN MARKET 62
5.3.1 DRIVERS 62
5.3.1.1 Growth in health consciousness among consumers and increasing health expenditure 62
FIGURE 22 INCREASING PER CAPITA HEALTH EXPENDITURE IN MAJOR ECONOMIES, 2015–2019 (USD) 63
5.3.1.2 Increase in application of beta-glucan in different industries 63
5.3.2 RESTRAINTS 64
5.3.2.1 Inconsistency in regulatory norms governing beta-glucan 64
5.3.2.2 Price volatility of raw materials 64
5.3.3 OPPORTUNITIES 65
5.3.3.1 Untapped beta-glucan applications 65
5.3.3.2 Rise in demand for natural and plant-based ingredients 65
5.3.4 CHALLENGES 66
5.3.4.1 Lack of consumer awareness regarding benefits specific to beta-glucan 66
6 INDUSTRY TRENDS 67
6.1 INTRODUCTION 67
6.2 VALUE CHAIN ANALYSIS 67
6.2.1 RESEARCH & DEVELOPMENT AND RAW MATERIAL SOURCING 67
6.2.2 MANUFACTURING 67
6.2.3 DISTRIBUTION 67
6.2.4 END USERS 68
FIGURE 23 BETA-GLUCAN MARKET: VALUE CHAIN ANALYSIS 68
6.3 SUPPLY CHAIN 68
FIGURE 24 BETA-GLUCAN MARKET: SUPPLY CHAIN ANALYSIS 68
6.3.1 SMOOTH PROCUREMENT OF RAW MATERIALS 69
6.3.2 DISTRIBUTION CHANNELS TO REDUCE DEMAND-SUPPLY GAP 69
6.4 TECHNOLOGY ANALYSIS 69
6.4.1 ENCAPSULATION 69
6.4.2 NEW AVENUES OF YEAST CULTURE & EXTRACTION 70
6.5 BETA-GLUCAN MARKET MAP AND ECOSYSTEM 70
6.5.1 DEMAND SIDE 70
6.5.2 SUPPLY SIDE 70
FIGURE 25 BETA-GLUCAN MARKET: ECOSYSTEM MAP 71
6.5.3 ECOSYSTEM MAP 71
TABLE 2 BETA-GLUCAN MARKET ECOSYSTEM 71
6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72
6.6.1 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN BETA-GLUCAN MARKET 72
FIGURE 26 REVENUE SHIFT IMPACTING TRENDS/DISRUPTIONS IN BETA-GLUCAN MARKET 72
6.7 PATENT ANALYSIS 73
FIGURE 27 PATENT ANALYSIS FOR BETA-GLUCAN MARKET, 2012–2022 73
FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED FOR BETA-GLUCAN, 2012–2022 74
6.7.1 LIST OF MAJOR PATENTS 74
6.8 PORTER’S FIVE FORCES ANALYSIS 76
6.8.1 THREAT OF NEW ENTRANTS 76
6.8.2 THREAT OF SUBSTITUTES 76
6.8.3 BARGAINING POWER OF SUPPLIERS 76
6.8.4 BARGAINING POWER OF BUYERS 77
6.8.5 INTENSITY OF COMPETITIVE RIVALRY 77

6.9 CASE STUDY ANALYSIS 77
6.9.1 CARGILL, INC.: INVESTMENT OF USD 35 MILLION IN EUROPE 77
6.9.2 TATE & LYLE PLC: EXTENDING ITS DISTRIBUTION PARTNERSHIP 78
6.10 TARIFF AND REGULATORY LANDSCAPE 78
6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
6.10.1.1 North America 78
TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
6.10.1.2 Europe 79
TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
6.10.1.3 Asia Pacific 80
TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
6.10.1.4 RoW 80
TABLE 6 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
6.11 REGULATIONS 81
6.11.1 INTRODUCTION 81
6.11.2 NORTH AMERICA 81
6.11.2.1 US Food and Drug Administration (21CFR101.14) 81
6.11.2.2 US Food and Drug Administration (21CFR101.81) 81
6.11.3 EUROPEAN FOOD SAFETY AUTHORITY 81
6.11.4 EUROPEAN UNION 81
6.12 KEY STAKEHOLDERS IN BUYING PROCESS 82
6.12.1 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 82
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS 82
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS 82
6.12.2 BUYING CRITERIA 83
FIGURE 30 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS ACROSS TOP APPLICATIONS 83
TABLE 8 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS ACROSS TOP APPLICATIONS 83
7 BETA-GLUCAN MARKET, BY SOURCE 84
7.1 INTRODUCTION 85
FIGURE 31 BETA-GLUCAN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION) 85
TABLE 9 BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 86
TABLE 10 BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 86
TABLE 11 BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 86
TABLE 12 BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 86

7.2 CEREALS & GRAINS 87
TABLE 13 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 87
TABLE 14 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 87
TABLE 15 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2018–2022 (TON) 88
TABLE 16 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2023–2028 (TON) 88
7.2.1 OATS 88
7.2.1.1 Increase in awareness of health benefits of beta-glucan from oats 88
7.2.2 BARLEY 89
7.2.2.1 Diverse applications of barley-based beta-glucan in various industries 89
7.2.3 OTHER SOURCES 89
7.3 MUSHROOM 90
7.3.1 D-GLUCAN FROM MUSHROOMS CATERS TO GROWTH IN DEMAND FOR IMMUNE SYSTEM-SUPPORTING INGREDIENTS 90
TABLE 17 MUSHROOM SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 90
TABLE 18 MUSHROOM SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 90
TABLE 19 MUSHROOM SOURCES MARKET, BY REGION, 2018–2022 (TON) 91
TABLE 20 MUSHROOM SOURCES MARKET, BY REGION, 2023–2028 (TON) 91
7.4 YEAST 91
7.4.1 GOVERNMENT SUPPORT FOR RESEARCH & DEVELOPMENT ON YEAST-BASED BETA-GLUCAN 91
TABLE 21 YEAST SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 92
TABLE 22 YEAST SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 92
TABLE 23 YEAST SOURCES MARKET, BY REGION, 2018–2022 (TON) 93
TABLE 24 YEAST SOURCES MARKET, BY REGION, 2023–2028 (TON) 93
7.5 SEAWEED 93
7.5.1 GROWING USE OF SEAWEED-BASED BETA-GLUCAN IN COSMETIC AND PERSONAL CARE PRODUCTS 93
TABLE 25 SEAWEED SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 94
TABLE 26 SEAWEED SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 94
TABLE 27 SEAWEED SOURCES MARKET, BY REGION, 2018–2022 (TON) 94
TABLE 28 SEAWEED SOURCES MARKET, BY REGION, 2023–2028 (TON) 95
8 BETA-GLUCAN MARKET, BY CATEGORY 96
8.1 INTRODUCTION 97
FIGURE 32 BETA-GLUCAN MARKET, BY CATEGORY, 2023 VS. 2028 (USD MILLION) 97
TABLE 29 BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 97
TABLE 30 GLOBAL BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 97
8.2 SOLUBLE BETA-GLUCAN 98
8.2.1 RISE IN PREVALENCE OF CHRONIC LIFESTYLE DISEASES 98
TABLE 31 SOLUBLE BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 98
TABLE 32 SOLUBLE BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 99
8.3 INSOLUBLE BETA-GLUCAN 99
8.3.1 POSITIVE EFFECTS OF INSOLUBLE BETA-GLUCAN ON HUMAN HEALTH 99
TABLE 33 INSOLUBLE BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 100
TABLE 34 INSOLUBLE BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 100
9 BETA-GLUCAN MARKET, BY TYPE 101
9.1 INTRODUCTION 101
9.2 1,3 BETA-GLUCAN 101
9.3 1,4 BETA-GLUCAN 101
9.4 1,6 BETA-GLUCAN 102
10 BETA-GLUCAN MARKET, BY APPLICATION 103
10.1 INTRODUCTION 104
TABLE 35 APPLICATION OVERVIEW 104
FIGURE 33 BETA-GLUCAN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 105
TABLE 36 BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 105
TABLE 37 BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 105
10.2 FOOD & BEVERAGES 106
10.2.1 BENEFITS OF DIET INCLUDING SOLUBLE FIBER IN MANAGING CHRONIC CONDITIONS 106
TABLE 38 BETA-GLUCAN MARKET IN FOOD & BEVERAGE APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 106
TABLE 39 BETA-GLUCAN MARKET IN FOOD & BEVERAGE APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 106
10.3 PERSONAL CARE 107
10.3.1 CONSUMERS’ DEMAND FOR NATURAL AND HEALTH INGREDIENTS IN PERSONAL CARE PRODUCTS 107
TABLE 40 BETA-GLUCAN MARKET IN PERSONAL CARE APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 107
TABLE 41 BETA-GLUCAN MARKET IN PERSONAL CARE APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 108
10.4 PHARMACEUTICALS 108
10.4.1 GOVERNMENT INVESTMENT IN BENEFITS OF BETA-GLUCAN IN PHARMACEUTICAL APPLICATIONS 108
TABLE 42 BETA-GLUCAN MARKET IN PHARMACEUTICAL APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 109
TABLE 43 BETA-GLUCAN MARKET IN PHARMACEUTICAL APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 109
10.5 DIETARY SUPPLEMENTS 109
10.5.1 INCREASE IN AWARENESS OF ASSOCIATED HEALTH BENEFITS 109
TABLE 44 BETA-GLUCAN MARKET IN DIETARY SUPPLEMENT APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 110
TABLE 45 BETA-GLUCAN MARKET IN DIETARY SUPPLEMENT APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 110
10.6 ANIMAL FEED 111
10.6.1 GROWING INCLINATION OF PET AND LIVESTOCK OWNERS TOWARD NUTRITIOUS FEED 111
TABLE 46 BETA-GLUCAN MARKET IN ANIMAL FEED APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 111
TABLE 47 BETA-GLUCAN MARKET IN ANIMAL FEED APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 112
11 BETA-GLUCAN MARKET, BY BRAND 113
11.1 INTRODUCTION 113
11.2 OATWELL 113
11.3 PROMOAT 113
11.4 SANACEL 113
11.5 AVENACARE 113
11.6 NUTRIM 113
11.7 WELLMUNE 114
11.8 YESTIMUN 114
12 BETA-GLUCAN MARKET, BY EXTRACTION METHOD 115
12.1 INTRODUCTION 115
TABLE 48 BETA-GLUCAN YIELDS AND PRODUCTION TECHNOLOGIES FROM VARIOUS SOURCES 115
12.2 BETA-GLUCAN FROM CEREAL 116
12.3 BETA-GLUCAN FROM YEAST 116
13 BETA-GLUCAN MARKET, BY REGION 117
13.1 INTRODUCTION 118
FIGURE 34 ASIA PACIFIC COUNTRIES TO WITNESS SIGNIFICANT GROWTH IN BETA-GLUCAN MARKET, 2023–2028 119
TABLE 49 GLOBAL BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 119
TABLE 50 BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 120
TABLE 51 BETA-GLUCAN MARKET, BY REGION, 2018–2022 (TON) 120
TABLE 52 BETA-GLUCAN MARKET, BY REGION, 2023–2028 (TON) 120
13.2 NORTH AMERICA 121
FIGURE 35 NORTH AMERICA: BETA-GLUCAN MARKET SNAPSHOT 122
13.2.1 NORTH AMERICA: RECESSION IMPACT 122
FIGURE 36 NORTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017–2021 123
FIGURE 37 NORTH AMERICA: RECESSION IMPACT ANALYSIS, 2023 124
TABLE 53 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 124
TABLE 54 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 125
TABLE 55 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 125
TABLE 56 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 125
TABLE 57 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 126
TABLE 58 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 126
TABLE 59 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 126
TABLE 60 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 126
TABLE 61 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 127
TABLE 62 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 127
13.2.2 US 127
13.2.2.1 Rise in awareness and consumption of fiber-rich ingredient-based products 127
TABLE 63 US: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 128
TABLE 64 US: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 128
TABLE 65 US: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 128
TABLE 66 US: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 129
13.2.3 CANADA 129
13.2.3.1 Increased potential usage in food & beverage and pharmaceutical applications in Canada 129
TABLE 67 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 130
TABLE 68 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 130
TABLE 69 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 130
TABLE 70 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 130
13.2.4 MEXICO 131
13.2.4.1 Support from government initiatives and public healthcare campaigns 131
TABLE 71 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 131
TABLE 72 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 131
TABLE 73 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 132
TABLE 74 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 132
13.3 EUROPE 132
13.3.1 EUROPE: RECESSION IMPACT 133
FIGURE 38 EUROPE: INFLATION RATES, BY KEY COUNTRY, 2017–2021 134
FIGURE 39 EUROPE: RECESSION IMPACT ANALYSIS, 2023 134
TABLE 75 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 135
TABLE 76 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 135
TABLE 77 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 135
TABLE 78 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 136
TABLE 79 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 136
TABLE 80 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 136
TABLE 81 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 137
TABLE 82 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 137
TABLE 83 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 137
TABLE 84 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 138
13.3.2 GERMANY 138
13.3.2.1 Rise in prevalence of diabetes and population inclining toward natural ingredient-based foods 138
TABLE 85 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 138
TABLE 86 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 139
TABLE 87 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 139
TABLE 88 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 139
13.3.3 FRANCE 139
13.3.3.1 Demand for functional foods in France 139
TABLE 89 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 140
TABLE 90 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 140
TABLE 91 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 140
TABLE 92 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 141
13.3.4 UK 141
13.3.4.1 Growth in natural ingredient trend in UK 141
TABLE 93 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 142
TABLE 94 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 142
TABLE 95 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 142
TABLE 96 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 142
13.3.5 ITALY 143
13.3.5.1 Significant rise in consumer demand for health-enriching ingredients in Italy 143
TABLE 97 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 143
TABLE 98 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 143
TABLE 99 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 144
TABLE 100 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 144
13.3.6 SPAIN 144
13.3.6.1 Rise in consumer awareness toward consumption of organic ingredients 144
TABLE 101 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 145
TABLE 102 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 145
TABLE 103 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 145
TABLE 104 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 146
13.3.7 REST OF EUROPE 146
TABLE 105 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 146
TABLE 106 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 147
TABLE 107 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 147
TABLE 108 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 147
13.4 ASIA PACIFIC 147
13.4.1 ASIA PACIFIC: RECESSION IMPACT 148
FIGURE 40 ASIA PACIFIC: INFLATION RATES, BY KEY COUNTRY, 2017–2021 149
FIGURE 41 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023 150
FIGURE 42 ASIA PACIFIC: BETA-GLUCAN MARKET SNAPSHOT 151
TABLE 109 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 151
TABLE 110 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 152
TABLE 111 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 152
TABLE 112 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 152
TABLE 113 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 153
TABLE 114 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 153
TABLE 115 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 153
TABLE 116 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 153
TABLE 117 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 154
TABLE 118 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 154
13.4.2 CHINA 154
13.4.2.1 Rise in preference for fortified products in China 154
TABLE 119 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 155
TABLE 120 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 155
TABLE 121 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 156
TABLE 122 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 156
13.4.3 INDIA 156
13.4.3.1 Innovation and product development in beta-glucan industry in India 156
TABLE 123 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 157
TABLE 124 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 157
TABLE 125 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 157
TABLE 126 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 157
13.4.4 JAPAN 158
13.4.4.1 Rise in healthcare costs and higher life expectancy due to preventive healthcare measures in Japan 158
TABLE 127 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 158
TABLE 128 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 158
TABLE 129 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 159
TABLE 130 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 159
13.4.5 AUSTRALIA & NEW ZEALAND 159
13.4.5.1 High spending capacity on nutritional products in ANZ 159
TABLE 131 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 160
TABLE 132 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 160
TABLE 133 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 160
TABLE 134 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 161
13.4.6 REST OF ASIA PACIFIC 161
TABLE 135 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 161
TABLE 136 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 162
TABLE 137 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 162
TABLE 138 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 162
13.5 SOUTH AMERICA 163
13.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS 163
FIGURE 43 SOUTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017–2021 164
FIGURE 44 SOUTH AMERICA: RECESSION IMPACT ANALYSIS, 2023 164
TABLE 139 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 165
TABLE 140 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 165
TABLE 141 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 165
TABLE 142 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 166
TABLE 143 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 166
TABLE 144 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 166
TABLE 145 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 167
TABLE 146 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 167
TABLE 147 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 167
TABLE 148 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 167
13.5.2 BRAZIL 168
13.5.2.1 Development of food & beverage industry due to inflow of FDI 168
TABLE 149 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 168
TABLE 150 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 168
TABLE 151 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 169
TABLE 152 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 169
13.5.3 ARGENTINA 169
13.5.3.1 Increase in consumer awareness regarding health benefits of beta-glucan in Argentina 169
FIGURE 45 ARGENTINA: HEALTH EXPENDITURE (SHARE OF GDP), 2012–2017 170
TABLE 153 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 170
TABLE 154 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 170
TABLE 155 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 171
TABLE 156 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 171
13.5.4 REST OF SOUTH AMERICA 171
TABLE 157 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 172
TABLE 158 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 172
TABLE 159 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 172
TABLE 160 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 173
13.6 REST OF THE WORLD (ROW) 173
13.6.1 ROW: RECESSION IMPACT 173
FIGURE 46 ROW: INFLATION RATES, BY KEY COUNTRY, 2017–2021 174
FIGURE 47 ROW: RECESSION IMPACT ANALYSIS, 2023 175
TABLE 161 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 175
TABLE 162 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 176
TABLE 163 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 176
TABLE 164 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 176
TABLE 165 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 177
TABLE 166 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 177
TABLE 167 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 177
TABLE 168 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 177
TABLE 169 ROW: BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 178
TABLE 170 ROW: BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 178
13.6.2 MIDDLE EAST 178
13.6.2.1 Increased health and wellness initiatives in Middle East 178
TABLE 171 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 179
TABLE 172 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 179
TABLE 173 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 179
TABLE 174 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 179
13.6.3 AFRICA 180
13.6.3.1 Growing demand for natural and functional ingredients in Africa 180
TABLE 175 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 180
TABLE 176 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 180
TABLE 177 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 181
TABLE 178 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 181
14 COMPETITIVE LANDSCAPE 182
14.1 OVERVIEW 182
14.2 MARKET SHARE ANALYSIS 182
TABLE 179 BETA-GLUCAN MARKET: DEGREE OF COMPETITION (FRAGMENTED), 2022 183
14.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS 183
FIGURE 48 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS, 2018–2022 (USD MILLION) 183
14.4 STRATEGIES ADOPTED BY KEY PLAYERS 184
TABLE 180 STRATEGIES ADOPTED BY KEY BETA-GLUCAN MANUFACTURERS 184
14.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS) 186
14.5.1 STARS 187
14.5.2 EMERGING LEADERS 187
14.5.3 PERVASIVE PLAYERS 187
14.5.4 PARTICIPANTS 187
FIGURE 49 BETA-GLUCAN MARKET: COMPANY EVALUATION QUADRANT, 2023 (KEY PLAYERS) 188
14.5.5 PRODUCT FOOTPRINT 189
TABLE 181 COMPANY FOOTPRINT, BY SOURCE 189
TABLE 182 COMPANY FOOTPRINT, BY APPLICATION 190
TABLE 183 COMPANY FOOTPRINT, BY REGION 191
TABLE 184 OVERALL COMPANY FOOTPRINT 192
14.6 COMPANY EVALUATION QUADRANT (STARTUPS/SMES) 193
14.6.1 PROGRESSIVE COMPANIES 193
14.6.2 STARTING BLOCKS 193
14.6.3 RESPONSIVE COMPANIES 193
14.6.4 DYNAMIC COMPANIES 193
FIGURE 50 BETA-GLUCAN MARKET: COMPANY EVALUATION QUADRANT, 2023 (STARTUPS/SMES) 194
14.6.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 195
TABLE 185 BETA-GLUCAN MARKET: DETAILED LIST OF KEY STARTUPS/SMES 195
TABLE 186 BETA-GLUCAN MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 196
14.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS 197
14.7.1 PRODUCT LAUNCHES 197
14.7.2 DEALS 197
TABLE 187 BETA-GLUCAN MARKET: DEALS, 2018–2022 197
14.7.3 OTHER DEVELOPMENTS 200
TABLE 188 BETA-GLUCAN MARKET: OTHER DEVELOPMENTS, 2018–2022 200
15 COMPANY PROFILES 204
15.1 KEY PLAYERS 204
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
15.1.1 TATE & LYLE PLC 204
TABLE 189 TATE & LYLE PLC: BUSINESS OVERVIEW 204
FIGURE 51 TATE & LYLE PLC: COMPANY SNAPSHOT 205
TABLE 190 TATE & LYLE PLC: PRODUCTS OFFERED 205
TABLE 191 TATE & LYLE PLC: DEALS 206
TABLE 192 TATE & LYLE PLC: OTHER DEVELOPMENTS 206
15.1.2 KERRY GROUP PLC 208
TABLE 193 KERRY GROUP PLC: BUSINESS OVERVIEW 208
FIGURE 52 KERRY GROUP PLC: COMPANY SNAPSHOT 209
TABLE 194 KERRY GROUP PLC: PRODUCTS OFFERED 209
15.1.3 KONINKLIJKE DSM N.V. 211
TABLE 195 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW 211
FIGURE 53 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT 212
TABLE 196 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED 212
TABLE 197 KONINKLIJKE DSM N.V.: OTHER DEVELOPMENTS 213
15.1.4 INTERNATIONAL FLAVORS & FRAGRANCES INC. 214
TABLE 198 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW 214
FIGURE 54 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT 215
TABLE 199 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS OFFERED 215
TABLE 200 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS 216
TABLE 201 INTERNATIONAL FLAVORS & FRAGRANCES INC.: OTHER DEVELOPMENTS 216
15.1.5 MERCK 218
TABLE 202 MERCK: BUSINESS OVERVIEW 218
FIGURE 55 MERCK: COMPANY SNAPSHOT 219
TABLE 203 MERCK: PRODUCTS OFFERED 219
TABLE 204 MERCK: OTHER DEVELOPMENTS 220
15.1.6 LESAFFRE HUMAN CARE 222
TABLE 205 LESAFFRE HUMAN CARE: BUSINESS OVERVIEW 222
TABLE 206 LESAFFRE HUMAN CARE: PRODUCTS OFFERED 222
TABLE 207 LESAFFRE HUMAN CARE: DEALS 223
15.1.7 KEMIN INDUSTRIES 225
TABLE 208 KEMIN INDUSTRIES: BUSINESS OVERVIEW 225
TABLE 209 KEMIN INDUSTRIES: PRODUCTS OFFERED 225
TABLE 210 KEMIN INDUSTRIES OTHER DEVELOPMENTS 226
15.1.8 ANGEL YEAST CO., LTD 227
TABLE 211 ANGEL YEAST CO., LTD: BUSINESS OVERVIEW 227
FIGURE 56 ANGEL YEAST CO., LTD: COMPANY SNAPSHOT 227
TABLE 212 ANGEL YEAST CO., LTD: PRODUCTS OFFERED 228
15.1.9 LALLEMAND 230
TABLE 213 LALLEMAND: BUSINESS OVERVIEW 230
TABLE 214 LALLEMAND: PRODUCTS OFFERED 230
TABLE 215 LALLEMAND: DEALS 231
15.1.10 OHLY GMBH 232
TABLE 216 OHLY GMBH: BUSINESS OVERVIEW 232
TABLE 217 OHLY GMBH: PRODUCTS OFFERED 232
15.1.11 BIORIGIN - ZILOR 234
TABLE 218 BIORIGIN - ZILOR: BUSINESS OVERVIEW 234
TABLE 219 BIORIGIN - ZILOR: PRODUCTS OFFERED 234
15.1.12 CEAPRO INC. 236
TABLE 220 CEAPRO INC: BUSINESS OVERVIEW 236
FIGURE 57 CEAPRO INC.: COMPANY SNAPSHOT 237
TABLE 221 CEAPRO INC: PRODUCT OFFERED 238
TABLE 222 CEAPRO INC: DEALS 238
TABLE 223 CEAPRO INC: OTHER DEVELOPMENTS 239
15.1.13 SPECIALTY BIOTECH CO., LTD. 240
TABLE 224 SPECIALTY BIOTECH CO., LTD.: BUSINESS OVERVIEW 240
TABLE 225 SPECIALTY BIOTECH CO., LTD.: PRODUCTS OFFERED 240
15.1.14 ALLTECH LIFE SCIENCES 241
TABLE 226 ALLTECH LIFE SCIENCES: BUSINESS OVERVIEW 241
TABLE 227 ALLTECH LIFE SCIENCES: PRODUCTS OFFERED 241
15.1.15 GLYCONOVA 243
TABLE 228 GLYCONOVA: BUSINESS OVERVIEW 243
TABLE 229 GLYCONOVA: PRODUCTS OFFERED 243
15.1.16 GARUDA INTERNATIONAL INC. 245
TABLE 230 GARUDA INTERNATIONAL INC.: BUSINESS OVERVIEW 245
15.1.17 VAN WANKUM INGREDIENTS 247
TABLE 231 VAN WANKUM INGREDIENTS: BUSINESS OVERVIEW 247
TABLE 232 VAN WANKUM INGREDIENTS: PRODUCTS OFFERED 247
15.1.18 SUPER BETA GLUCAN 249
TABLE 233 SUPER BETA GLUCAN: BUSINESS OVERVIEW 249
TABLE 234 SUPER BETA GLUCAN: PRODUCTS OFFERED 249
15.1.19 LEIBER GROUP GMBH & CO KG 251
TABLE 235 LEIBER GROUP GMBH & CO KG: BUSINESS OVERVIEW 251
TABLE 236 LEIBER GROUP GMBH & CO KG: PRODUCTS OFFERED 251
15.1.20 NUTRISCIENCE INNOVATIONS 253
TABLE 237 NUTRISCIENCE INNOVATIONS: BUSINESS OVERVIEW 253
TABLE 238 NUTRISCIENCE INNOVATIONS: PRODUCTS OFFERED 253
15.1.21 EMBRIA HEALTH SCIENCES LLC 254
15.1.22 NUTRAQ 254
15.1.23 ABAC R&D AG 255
15.1.24 GLUCAN CORPORATION 255
15.1.25 TRANSFER POINT, INC. 256
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
16 ADJACENT & RELATED MARKETS 257
16.1 INTRODUCTION 257
TABLE 239 ADJACENT MARKETS 257
16.2 STUDY LIMITATIONS 257
16.3 FEED FLAVORS AND SWEETENERS MARKET 257
16.3.1 MARKET DEFINITION 257
16.3.2 MARKET OVERVIEW 257
TABLE 240 FEED SWEETENERS MARKET, BY TYPE, 2015–2022 (USD MILLION) 258
TABLE 241 FEED SWEETENERS MARKET, BY TYPE, 2015–2022 (KT) 258
16.4 STARTER CULTURE MARKET 259
16.4.1 MARKET DEFINITION 259
16.4.2 MARKET OVERVIEW 259
TABLE 242 STARTER CULTURE MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 260
TABLE 243 STARTER CULTURE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 260
17 APPENDIX 261
17.1 DISCUSSION GUIDE 261
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 265
17.3 CUSTOMIZATION OPTIONS 267
17.4 AUTHOR DETAILS 268

ページTOPに戻る

Table of Contents

Summary

The beta-glucan market is projected to grow from USD 501 Million in 2023 to USD 734 Million by 2028, at a CAGR of 7.9% during the forecast period. The market is anticipated to grow due to increasing demand for use of natural additives in the food and beverage products, growing consumption of healthy diets with high fiber, rising surge in acceptance for beta-glucan for its several health-benefits. Such factors have driven the need to develop and deploy new products for beta-glucan. D
The segment grain & cereal is expected to account for the largest share in 2023.
Cereals and grains are known for their relatively high beta-glucan content compared to other food sources. For example, oats and barley contain particularly high levels of beta-glucan, with oats being one of the richest dietary sources. The beta-glucans in cereals and grains are typically of the mixed-linkage type, which has been shown to have favorable health effects, such as immune-modulating and cholesterol-lowering properties. The high beta-glucan content of cereals and grains makes them a desirable source for extracting this beneficial compound.

The food and beverage segment is projected to dominate the market in the application segment during the forecast period.
Based on the application segment, the food and beverage segment is projected to dominate the market during the forecast period. The rising awareness among the consumers for healthy diets, use of beta-glucan in bakery, chewing gums, milk and protein beverages, instant drinks and many others has led to the adoption of beta-glucan.
Asia Pacific is expected to account for the fastest market share in 2023.
The beta-glucan market industry has been studied in North America, Europe, Asia Pacific, Latin America and Rest of the World. Asia Pacific accounted for the fastest market during the forecast period of 2023-2028. The Asia Pacific market will experience considerable growth in the next years because of easy availability of raw materials in the Asia Pacific countries such as China and India, growing healthy food consumption patterns and increasing use of cosmetic products in countries like Japan and South Korea.

The break-up of the profile of primary participants in the beta-glucan market:
• By Value Chain: Manufacturers-85%, Suppliers-15%
• By Designation: CXOs – 33.7%, Managers – 44%, Executives-22.3%
• By Region: North America – 60%, Europe – 18%, Asia Pacific – 10%, South America – 8%, and Rest of the World – 4%
Prominent companies include Tate & Lyle PLC (England), Kerry Group PLC (Ireland), Koninklijke DSM NV (Netherlands), International Flavors & Fragrances INC. (US), Merck (US).
Research Coverage:
This research report categorizes the beta-glucan market by Source (Grains & Cereals, Mushrooms, Yeast and Seaweed), Category (Soluble and Insoluble), Application (Food & Beverage, Personal Care, Pharmaceutical, Dietary Supplement and Animal Feed), and region (North America, Europe, Asia Pacific, South America and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of beta-glucan market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the de-oiled lecithin market. Competitive analysis of upcoming startups in the de-oiled lecithin market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall beta-glucan market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (Growing health consciousness among consumers and increasing health expenditure, Growing application of beta-glucan in different industries), restraints (Inconsistency in regulatory norms governing beta-glucan), opportunity (Untapped beta-glucan applications), and challenge (Lack of consumer awareness) influencing the growth of the beta-glucan market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the beta-glucan market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the beta-glucan market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the beta-glucan market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Tate & Lyle PLC (England), Kerry Group PLC (Ireland), Koninklijke DSM NV (Netherlands), International Flavors & Fragrances INC. (US) and Merck (US) among others in the beta-glucan market strategies. The report also helps stakeholders understand the starter culture market and provides them information on key market drivers, restraints, challenges, and opportunities.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（農産食品）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（beverage）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

β-グルカン市場：供給源（穀類、キノコ、酵母、海藻）、用途（食品・飲料、パーソナルケア、医薬品、栄養補助食品、動物飼料）、地域（北米、欧州、APAC、中南米、RoW）別 - 2028年までの世界予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（農産食品）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（beverage）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?